IIL in the News
Be in-the-know of the latest advances in the organisation.
Indian Immunologicals working on bi-valent human monoclonal antibody for rabies
Indian Immunologicals Ltd is working on a bi-valent monoclonal antibody for rabies
India: Kerala's anti-rabies campaign
A major public health issue kicks off efforts against dog-mediated rabies
Indian Immunologicals unveils IVF media for bovine embryo transfer developed in partnership with NDDB
The public sector vaccine maker is set to make the IVF technology more affordable to farmers, enhance the farmer-centric model of animal husbandry and dairy development
Indian Immunologicals, Indian Council of Medical Reaearch ink pact for Zika vaccine
The vaccine maker and the national research body have entered into an agreement for the development of the country’s first codon de-optimised live attenuated Zika vaccine, a press release said
Indian Immunologicals unveils paediatric dose of indigenous hepatitis A vaccine, Havisure
Hyderabad-based Indian Immunologicals Limited (IIL) has announced the launch of its latest breakthrough- the paediatric dose of India's first indigenous Hepatitis A vaccine, Havisure (0.5 ml).
Indian Immunologicals Limited, continues its Fish Vaccine development and signs agreement with ICAR-CIBA
Hyderabad – Indian Immunologicals Limited (IIL), a leading vaccine manufacturer, has announced partnership with Central Institute of Brackishwater Aquaculture (CIBA),
Indian Immunologicals Limited Collaboratively Develops Game-changing Needle-free COVID-19 Intranasal Vaccine
The danger due to COVID 19 is still not over. It is still killing around 1,700 people a week around the world.
Indian Immunologicals donates 10,000 anti-rabies vaccine doses in Vietnam
Company’s Zika vaccine is entering clinical trial phase, while its KFD vaccine is at later stages of vaccine development
Indian Immunologicals Hosts Free Vaccination Drive For Over A Lakh Canine On Zoonosis Day
Mumbai – Indian Immunologicals Limited (IIL) has conducted free anti-rabies vaccination to over a lakh canine across the country on the eve of the Zoonosis Day.
Indian Immunologicals unveils indigenously developed Hepatitis A vaccine
MRP set at ₹2,150 per shot for the two-dose Havisure that has been launched after years of R&D, extensive clinical trials as well as a non-inferiority study, says MD K Anand Kumar
Indian Immunologicals launches measles and rubella vaccine for children
Developed in partnership with Polyvac Institute of Vietnam, IIL launched Mabella vaccine as part of the 25th celebrations of Human Biologicals Institute
IIL launches virtual medical representatives
eMOz will eventually be acquiring AI avatars of sales representatives to interact and assist physicians in one of its kind experiences
Indian Immunologicals set to roll out Hepatitis A and MR vaccines in 2023
Hyderabad-based vaccine manufacturer Indian Immunologicals Limited (IIL) is all ready to launch vaccines for Hepatitis A (Hep A) and for Measles and Rubella (MR) in 2023.
IIL deploys drones to transport animal vaccines
Drone delivery of vaccines not only reaches remote terrains faster but also helps in providing vaccines on time for the protection of livestock
Indian Immunologicals to set up ₹700 crore plant in Hyderabad’s Genome Valley
A veterinary vaccine facility, it will grow Genome Valley’s presence, make jabs for FMD, other emerging diseases, create jobs for 750 people National Dairy Development Board subsidiary Indian Immunologicals (IIL) will be investing about ₹700 crore to set up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad.
Indian Immunologicals invests Rs 700 Cr in new animal vaccine facility in Hyderabad
Indian Immunologicals Limited (IIL) has announced that the company will invest about Rs 700 crore to set up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad - the “Vaccine Hub of the World”, to meet the vaccine security of the nation against economically important diseases such as Foot and Mouth disease (FMD) and other emerging diseases. The facility will create total employment for around 750 people.
INDIA’S LEADING VACCINE MAKER, INDIAN IMMUNOLOGICALS LTD, EXPANDS NEW ZEALAND OPERATIONS
Dr. K. Anand Kumar, Managing Director, Indian Immunologicals Ltd expresses his views with Indian Weekender, on IIL's expansion of its subsidiary, Pristine Biologicals in Dargaville North Island, New Zealand.
Indian Immunologicals Ltd to expand New Zealand Operations
The facility was inaugurated by Shri Meenesh C. Shah, Chairman of Indian Immunologicals Ltd and National Dairy Development Board, in the presence of Dr. Jason Smith, the Hon Mayor of Dargaville, Dr. K. Anand Kumar, Managing Director, IIL, Dr. Vijay Dasari, GM and Director, Pristine Biologicals (NZ) Limited and many dignitaries
IIL's subsidiary Pristine Biologicals NZ inaugurates new sterile filtered serum manufacturing facility in Dargaville, New Zealand
Pristine Biologicals NZ Ltd, a subsidiary of Indian Immunologicals Ltd (IIL) - one of the largest producers of vaccines in India, which belongs to the National Dairy Development Board (NDDB) in India has inaugurated a new facility in Dargaville, New Zealand today for the production of sterile filtered serum.
Indian Immunologicals Ltd To Expand New Zealand Operations
The requirement for bovine serum from New Zealand for use in biologics manufacture has gone up many folds and to meet the demands of the world markets, it is important to augment the capacities and also bring in more value-added products, the company feels
Pristine Biologicals inaugurates New Sterile Filtered Serum manufacturing facility in New Zealand’s Dargaville
The requirement for bovine serum from New Zealand for use in biologics manufacture has gone up many folds and to meet the demands of the world markets, it is important to augment the capacities and also bring in more value-added products, the company claimed.
Indian Immunologicals to expand New Zealand operations
Indian Immunologicals Limited (IIL), the vaccine maker under the National Dairy Development Board (NDDB), has announced expansion of operations in New Zealand through its subsidiary Pristine Biologicals NZ.
Pristine Biologicals inaugurates new facility in Dargaville, NZ
The facility was established in Dargaville, Kaipara District in 2015 for the production and supply of pharmaceutical grade bovine serum used to produce many vaccines and is considered a very successful venture. It is pertinent to note that the serum from New Zealand and Australia has premium value since those countries are free from OIE listed diseases.
IIL's subsidiary Pristine Biologicals NZ opens serum manufacturing facility in Dargaville, NZ
Pristine Biologicals NZ, a subsidiary of Indian Immunologicals Ltd (IIL) has inaugurated a new facility in Dargaville for the production of sterile-filtered serum. The facility was inaugurated by Meenesh C Shah, Chairman of Indian Immunologicals and National Dairy Development Board, in the presence of Dr Jason Smith, the Mayor of Dargaville, Dr K Anand Kumar, MD, IIL, Dr Vijay Dasari, GM and Director, Pristine Biologicals (NZ) and many dignitaries.
Indian Immunologicals launches Goat Pox Vaccine
Indian Immunologicals Ltd (IIL) has launched Goat Pox Vaccine (Raksha Goat Pox) which is expected to help Control of Goat Pox disease.
IIL donates oxygen generation plant to TIMS, Gachibowli
Indian Immunologicals Limited (IIL) donated a PSA Oxygen Generation Plant to the Telangana Institute of Medical Sciences (TIMS), Gachibowli for service to patients in need of oxygen support.
The pandemic’s silent saviours
We salute the scientists who’ve been working behind the scenes, combating the coronavirus
Govt lauds Indian Immunologicals for producing Covid-19 vaccine drug substance in record time
Hyderabad: Union Fisheries, Animal Husbandry, and Dairying minister Parshottam Rupala lauded the efforts of Indian Immunologicals Limited (IIL) for its ability to roll out Covid-19 vaccine drug substance in record time.
Union Minister Parshottam Rupala lauds IIL for producing COVID-19 drug substance in record time
New Delhi [India], September 24 (ANI): Union Fisheries, Animal Husbandry, and Dairying Minister, Parshottam Rupala lauded the efforts of Indian Immunologicals Limited (IIL) for their ability to roll out the COVID-19 vaccine drug substance in record time.
Govt lauds IIL, BBIL's effort in COVID-19 vaccine production
Union Fisheries, Animal Husbandry, and Dairying Minister, Parshottam Rupala hands over COVID-19 drug substance made at IIL to Dr Krishna Ella, CMD, BBIL
Indian Immunologicals to ramp up production of input for Covaxin
This was disclosed by the Hyderabad-based IIL during the visit of Union Minister Parshottam Rupala